Med. praxi. 2021;18(2):98-103 | DOI: 10.36290/med.2021.016
Effective doctor-patient communication is the key to success
- 1 3. interní klinika VFN a 1. LF UK Praha
- 2 Interní klinika FNKV a 3. LF UK Praha
Hypertension and dyslipidaemia are two cardiovascular risk factors that often co-occur. This may even be the case in relatively young people. There is evidence that early simultaneous control of these risk factors potentiates patient benefit. However, particularly in younger individuals, low adherence to the management of cardiovascular risk factors is encountered. The adherence to recommended pharmacological as well as non-pharmacological interventions can be improved by proper doctor-patient communication, such as communicating cardiovascular risk to patients using the vascular age concept. A simple pharmacotherapy regimen utilizing fixed drug combinations is an important tool for increasing adherence. Examples of communication between a doctor and a patient with hypertension and dyslipidaemia can be an inspiration.
Keywords: dyslipidaemia, arterial hypertension, cardiovascular risk, adherence, vascular age.
Published: April 30, 2021 Show citation
References
- Gupta A, Mackay J, Whitehouse A, et al. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial [published correction appears in Lancet 2018; 392(10156): 1402]. Lancet 2018; 392(10153): 1127-1137.
Go to original source... 
Go to PubMed... - Chmelík Z, Vrablík M, Vaclová M, Lánská V. Vysoká prevalence kardiovaskulárnîch rizikových faktorů a neuspokojivá kontrola hladin LDL-cholesterolu v populaci 40letých mužů a 50letých žen v České republice. AtheroRev 2016; 1(3): 111-115.
- Šatný M, Tůmová E, Vrablîk M. LIPIcontrol: dařî se zlepšovat úroveň kontroly hlavnîch rizikových faktorů kardiovaskulárnîch onemocněnî v každodennî praxi? Hypertenze & kardiovaskulárnî prevence 2018; 1: 15-21.
- Widimský J, et al. Doporučenî pro diagnostiku a léčbu arteriálnî hyperteze ČSH 2017. Hypertenze a KV prevence 2018, 7: 1-20.
- Cuende JI, Cuende N, Calaveras-Lagartos J. How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation. Eur Heart J. 2010; 31(19): 2351-2358. Go to original source... Go to PubMed...
- Cuende JI. Vascular Age Versus Cardiovascular Risk: Clarifying Concepts. Rev Esp Cardiol (Engl Ed). 2016; 69(3): 243-246. Go to original source... Go to PubMed...
- Chowdhury R, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences, European Heart Journal 2013; 34(38): 2940-2948. Go to original source... Go to PubMed...
- Herttua K, et al. Poor Adherence to Statin and Antihypertensive Therapies as Risk Factors for Fatal Stroke. J Am Coll Cardiol. 2016; 67(13): 1507-1515. Go to original source... Go to PubMed...
- De Vera MA, Bhole V. Burns LC, Lacaille D. Impact of statin adherence. Br J Clin Pharmacol. 2014; 78: 684-698. Go to original source... Go to PubMed...
- Herttua K, Martikainen P, Batty GD, Kivimäki M. Poor Adherence to Statin and Antihypertensive Therapies as Risk Factors for Fatal Stroke. J Am Coll Cardiol. 2016; 67(13): 1507-1515. Go to original source... Go to PubMed...
- Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010; 55(2): 399-407. Go to original source... Go to PubMed...
- Sherrill B, Halpern M, Khan S, Zhang J, Panjabi S. Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens (Greenwich) 2011; 13(12): 898-909. Go to original source... Go to PubMed...